Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy. - Wikidata - wikimedia - TriplyDB

Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy.

Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy.

http://www.wikidata.org/entity/Q48229967

about

Neuroinflammation in the peripheral nerve: Cause, modulator, or bystander in peripheral neuropathies?Neuro-glial interactions at the nodes of Ranvier: implication in health and diseases Node of Ranvier disruption as a cause of neurological diseases Mapping autoantigen epitopes: molecular insights into autoantibody-associated disorders of the nervous system Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg.Contactin-1 and Neurofascin-155/-186 Are Not Targets of Auto-Antibodies in Multifocal Motor Neuropathy Chronic inflammatory demyelinating polyneuropathy (CIDP): change of serum IgG dimer levels during treatment with intravenous immunoglobulins.Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype.Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy.Contactin 1 IgG4 associates to chronic inflammatory demyelinating polyneuropathy with sensory ataxia Immunotherapy in Peripheral Neuropathies Protein array-based profiling of CSF identifies RBPJ as an autoantigen in multiple sclerosis.Specific contactin N-glycans are implicated in neurofascin binding and autoimmune targeting in peripheral neuropathies.Association of rs1568885, rs1813443 and rs4411591 polymorphisms with anti-TNF medication response in Greek patients with Crohn's disease.To look for a needle in a haystack: the search for autoantibodies in multiple sclerosis.Chronic inflammatory demyelinating polyradiculoneuropathy and variants: where we are and where we should go.Optimizing IgG therapy in chronic autoimmune neuropathies: a hypothesis driven approach.Dysregulated expression of lipid storage and membrane dynamics factors in Tia1 knockout mouse nervous tissue.Autoimmune antigenic targets at the node of Ranvier in demyelinating disorders.Progress in inflammatory neuropathy -the legacy of Dr Jack Griffin.Intravenous immunoglobulin: pharmacological properties and use in polyneuropathies.Evaluation of patients with refractory chronic inflammatory demyelinating polyneuropathy.Autoantibodies in chronic inflammatory neuropathies: diagnostic and therapeutic implications.Co-cultures with stem cell-derived human sensory neurons reveal regulators of peripheral myelination.Diagnostic Utility of Auto Antibodies in Inflammatory Nerve Disorders.Reply: biomarkers of 'acute-onset' chronic inflammatory demyelinating polyneuropathy.Biomarkers of 'acute-onset' chronic inflammatory demyelinating polyneuropathy Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins.Antibodies against peripheral nerve antigens in chronic inflammatory demyelinating polyradiculoneuropathy.Disruption of nodal architecture in skin biopsies of patients with demyelinating neuropathies.Anti-NF155 chronic inflammatory demyelinating polyradiculoneuropathy strongly associates to HLA-DRB15.Neurofascin antibodies in autoimmune, genetic, and idiopathic neuropathies.Maintenance IV immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy.ARTHUR ASBURY LECTURE: Chronic inflammatory demyelinating polyradiculoneuropathy: clinical aspects and new animal models of auto-immunity to nodal components.IgG4-mediated autoimmune diseases: a niche of antibody-mediated disorders.Glycosylphosphatidylinositol-Anchored Immunoglobulin Superfamily Cell Adhesion Molecules and Their Role in Neuronal Development and Synapse Regulation.Auto-antibodies to contactin-associated protein 1 (Caspr) in two patients with painful inflammatory neuropathy.Mechanisms of Caspr2 antibodies in autoimmune encephalitis and neuromyotonia.Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies.Paranodal destruction and axo-glial dysjunction in a subtype of CIDP with anticontaction-1 antibodies.

P2860

Q26801349-44C58356-43EE-4F69-B371-060937CD5EF7 Q26825224-13CCD21D-5BD6-48A4-B06C-E674180F47C9 Q27009974-4DA4665D-3FD6-475F-9424-1ACCFA274C62 Q28075974-075A32BF-873B-4E84-8D36-025DBEC5737B Q30574385-334D7B6B-8F31-4419-AD5C-B3914DE879A6 Q35719847-FE9D4C73-1A69-4B47-B9DC-928F2EF8DDA6 Q35950471-851F51BA-7174-4EC7-A30D-B2E8F57D38FB Q36005389-BFEBAD98-4F5C-4509-9448-58C8AED3456A Q36154796-A5F4C634-64A7-42FF-873A-998DCC455A58 Q36186804-B7D7A57A-A9FF-4D8E-9BB5-78304F3BF5F0 Q36484418-0A97ED2B-81C3-4BD4-87EC-C2B093567175 Q37463568-12D01457-EDE5-4B73-A096-F0DACE421FC1 Q37635865-A7DD2550-C5EC-41B2-B442-9AEFE0DAECA9 Q37682521-60D7CF69-E7F5-40FF-88AD-4B550D847F09 Q38192844-E1E61D19-E88E-448F-BD66-A47A199872DC Q38194642-F3E2E5E2-F93F-484F-98CE-66A69FF5FC77 Q38270717-A0B82CF9-7DA8-4638-9D3D-6276470CFA9B Q38308258-6EE8A5C9-6CD9-439A-A4A1-60562D1F2C3C Q38333532-D8678CB2-E760-4B97-8E75-14497CAF9BAC Q38605062-49E5ACC9-DE2D-44FB-B073-01D7FB0AF3D3 Q38900642-6EC170E2-C4FF-465E-B7DA-BC9963789469 Q38910047-2FC666F7-6BF7-4E02-BA3F-F0B891D4ED18 Q39434973-095AEF94-5492-4605-B55E-71EE5B69E480 Q40281429-14AB131D-AE5F-40BF-8351-A0AA03C6AAB2 Q41189967-27B54602-ED8A-4159-BB2F-84109CC28892 Q42590913-FB66AD67-856C-4984-9E31-36AF04B9090B Q42590915-50BC9D7D-B795-42C4-B2F5-F19DEDD4E316 Q43114504-1E4E1F75-B1FB-415A-8A34-96460ADB44D6 Q43533051-84B90381-5C48-46CC-8B12-C2538BC4D534 Q44424031-CFD2A098-5876-4804-B6EE-3193F3EAEB8F Q46866734-BDB3973D-4544-4604-AF8E-6FCD2FF3B590 Q47327481-9D78C679-B389-43C9-BEF5-BBA58A9FBD0B Q47584292-8AA25A68-F886-4143-A696-9D47131E0EB0 Q47610103-55CF87C8-A28D-4F83-B573-55E52672759E Q47707731-095EC136-8F46-4E08-A9F7-AA799C0FF2D6 Q47910942-BE338839-DDBA-4A82-9C70-8F127B581038 Q48033560-207DB455-8691-4787-9222-7A00DB202CFA Q48110568-BCBBFBF0-1EC3-4BB3-9C07-32D5A1D1603C Q48112518-F6F7668F-6395-4CDE-AD26-49CE628AF690 Q48217659-05EAA424-1D1A-4A2A-908C-ED940FD7AA2D

P2860

Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy.

http://www.wikidata.org/entity/Q48229967

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy.

@en

Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy.

@nl

type

label

Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy.

@en

Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy.

@nl

prefLabel

Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy.

@en

Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy.

@nl

P1433

Q48229967-B5C0D5EA-FBFE-45E9-BB28-0F03553927AC

P1476

Q48229967-F81F1C41-342F-4F51-8F72-85672CC88C51

P2093

Q48229967-14D9FB3C-D893-4FC7-9158-BA1E6FC11699

Q48229967-250EBA98-FE85-4E44-8845-C041A5BED99A

Q48229967-437E5F99-1C1D-44CC-BB38-A5BADCB570DF

Q48229967-47C05CE1-B7C0-4A62-BD96-91BBB4C20554

Q48229967-52EABE05-D570-4B70-B2F3-76FF5840BAE4

P2860

Q48229967-0C00F44E-352C-497F-94C8-2AA103B62175

Q48229967-253FF84A-3DFB-4B94-A383-36F31E08891C

Q48229967-29274003-D275-41AB-A369-9CEB996563B5

Q48229967-31BFD06B-DB32-45E2-B49D-F83356674E77

Q48229967-396EC650-47D4-4EA1-82B9-6EB88D6D5F1F

Q48229967-3DB0E4E1-8679-4C38-8F52-6CB7F832701A

Q48229967-41B3E393-B8AF-4303-AE63-C9C50FBBF4FB

Q48229967-69D2CD89-7CF7-4CD9-A86A-0A6A942B93C6

Q48229967-8107F11C-AB42-447F-B1B6-F23E8329A6AC

Q48229967-83A13419-1D3B-416C-BF24-C557618F8459

P304

Q48229967-655F3C9B-4A7E-476A-A947-A7D4D74EEF13

P31

Q48229967-12AE1321-22CA-4D23-82AF-DA6698B698D5

P356

Q48229967-B7E723C9-7E88-4B09-8243-57346D0372A0

P433

Q48229967-AA7557BB-92C0-47B3-BEB7-9133410B8CCB

P478

Q48229967-5431A897-0775-4480-89D7-9C56463A39F5

P50

Q48229967-353F319F-8D5E-451B-B0C9-A82DF7292221

Q48229967-54867D97-3303-4DD1-9B5C-C3569E51E5E6

Q48229967-6EF56E19-5526-47E5-BC70-45E175557F33

Q48229967-E1F61629-ABBE-4C85-BE9B-6C24D3FC8851

Q48229967-F79EEEC3-0E9F-4B2F-A092-27BB5339E0AF

P577

Q48229967-D87347A6-6BA4-4AFF-B46A-3A076466DD03

P5875

Q48229967-36380F24-84DD-487B-8EA9-D98F2EAF4FCA

P698

Q48229967-AFD78C84-5AA5-4BC0-81A8-5AC338718388

P921

Q48229967-C1F67D7D-76D4-4E6E-ABC9-48258A9BBA25

Q48229967-E88D8120-1EA1-4FDD-AB45-1878C0FDDDEC

P356

P1433

Annals of Neurology

P1476

Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy.

@en

P2093

Gisela Nogales-Gadea

http://www.w3.org/2001/XMLSchema#string

Isabel Illa

http://www.w3.org/2001/XMLSchema#string

Josefa Araque

http://www.w3.org/2001/XMLSchema#string

Luis Querol

http://www.w3.org/2001/XMLSchema#string

Ricard Rojas-Garcia

http://www.w3.org/2001/XMLSchema#string

P2860

A novel Caspr mutation causes the shambling mouse phenotype by disrupting axoglial interactions of myelinated nerves

In-gel digestion for mass spectrometric characterization of proteins and proteomes

Axon-glia interactions and the domain organization of myelinated axons requires neurexin IV/Caspr/Paranodin.

Nodes of ranvier and paranodes in chronic acquired neuropathies

Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series

Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia

Single nucleotide polymorphism of TAG-1 influences IVIg responsiveness of Japanese patients with CIDP.

Immune mechanisms in chronic inflammatory demyelinating neuropathy.

Chronic inflammatory demyelinating polyneuropathy.

Antibody responses to peptides of peripheral nerve myelin proteins P0 and P2 in patients with inflammatory demyelinating neuropathy.

P304

370-380

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.23794

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

73

http://www.w3.org/2001/XMLSchema#string

P50

Xavier Suárez-Calvet

Jordi Díaz-Manera

Eugenia Martinez-Hernandez

Eduard Gallardo

P577

2012-12-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234031867

http://www.w3.org/2001/XMLSchema#string

P698

23280477

http://www.w3.org/2001/XMLSchema#string

P921